These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 6134445

  • 1. Carbidopa/levodopa therapy of coexistent drug-induced parkinsonism and tardive dyskinesia.
    Shoulson I.
    Adv Neurol; 1983; 37():259-66. PubMed ID: 6134445
    [No Abstract] [Full Text] [Related]

  • 2. Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy.
    Bitton V, Melamed E.
    J Clin Psychiatry; 1984 Jan; 45(1):28-30. PubMed ID: 6141157
    [Abstract] [Full Text] [Related]

  • 3. Portable device for quantifying parkinsonian wrist rigidity.
    Caligiuri MP.
    Mov Disord; 1994 Jan; 9(1):57-63. PubMed ID: 7908119
    [Abstract] [Full Text] [Related]

  • 4. What to do when Sinemet fails: Part one.
    Klawans HL.
    Clin Neuropharmacol; 1984 Jan; 7(2):121-33. PubMed ID: 6733692
    [No Abstract] [Full Text] [Related]

  • 5. Controlled-release carbidopa-levodopa: old drug--new drug. Introduction.
    Koller WC.
    Neurology; 1992 Jan; 42(1 Suppl 1):4-5; discussion 57-60. PubMed ID: 1549200
    [No Abstract] [Full Text] [Related]

  • 6. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.
    Nyholm D, Nilsson Remahl AI, Dizdar N, Constantinescu R, Holmberg B, Jansson R, Aquilonius SM, Askmark H.
    Neurology; 2005 Jan 25; 64(2):216-23. PubMed ID: 15668416
    [Abstract] [Full Text] [Related]

  • 7. Long-term treatment of tardive dyskinesia with presynaptically acting dopamine-depleting agents.
    Fahn S.
    Adv Neurol; 1983 Jan 25; 37():267-76. PubMed ID: 6858776
    [Abstract] [Full Text] [Related]

  • 8. Parkinson's disease.
    Barboi AC, Goetz CG.
    Clin Neuropharmacol; 1999 Jan 25; 22(4):184-91. PubMed ID: 10442246
    [No Abstract] [Full Text] [Related]

  • 9. Coexistent tardive dyskinesia and parkinsonism.
    Jankovic J, Casabona J.
    Clin Neuropharmacol; 1987 Dec 25; 10(6):511-21. PubMed ID: 2892586
    [Abstract] [Full Text] [Related]

  • 10. Treatment of Parkinson's disease with controlled-release Carbidopa/L-DOPA.
    Pahwa R, Koller WC.
    Adv Neurol; 1996 Dec 25; 69():487-91. PubMed ID: 8615169
    [No Abstract] [Full Text] [Related]

  • 11. Parkinson's disease.
    Lieberman AN.
    Compr Ther; 1986 Mar 25; 12(3):25-9. PubMed ID: 3486090
    [No Abstract] [Full Text] [Related]

  • 12. Parkinson's disease improvement after the addition of levodopa-carbidopa to anticholinergic treatment. An open controlled study.
    Agnoli A, Ruggieri S, Denaro A, Lelli A.
    Acta Neurol (Napoli); 1978 Oct 25; 33(5):436-42. PubMed ID: 756675
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.